S
ShionogiJapanese pharmaceutical company developing prescription drugs, infectious disease therapies, and specialty medicines, including a former sleep apnea drug joint venture with Apnimed.
2 Pulse stories
TB
Triveni BioTriveni Bio develops genetics-informed antibody and bispecific therapeutics for immunological and inflammatory diseases.
2 Pulse stories
Total Raised
$272M
ShionogiTriveni Bio
Last ValuationNot disclosed
Biotech
Sector
Biotech
1878
Founded
2023
Osaka, Japan
HQ
Waltham, Massachusetts
Public (4507.T)
Status
Private
Shionogi investors
No investors on record.
Triveni Bio investors
Atlas VentureCormorant Asset ManagementAscenta CapitalJanus Henderson InvestorsDeep Track CapitalOrbiMedViking Global InvestorsFidelity Management & Research
Data from Value Add Pulse coverage and company research — see the full threads for Shionogi and Triveni Bio.